Effect of MD1003 in Amyotrophic Lateral Sclerosis

NCT03114215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS
Amyotrophic Lateral Sclerosis
Motor Neuron Disease

Interventions

DRUG: MD1003
DRUG: Placebo oral capsule

Sponsor

MedDay Pharmaceuticals SA